Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Ehninger

Showing results (241-250 of 403) with videos related to

Pageof 41
Sort By:
British Journal of Haematology|January 21, 2017
The TP53 Pro72Arg SNP in de novo acute myeloid leukaemia - results of two cohort studies involving 215 patients and 3759 controlsEduard Schulz, Karin Lind, Wilfried Renner, et al.
Blood|February 24, 2021
Proof of concept for a rapidly switchable universal CAR-T platform with UniCAR-T-CD123 in relapsed/refractory AMLMartin Wermke, Sabrina Kraus, Armin Ehninger, et al.
Haematologica|March 4, 2017
Impact of ABO incompatibility on patients' outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the Acute Leukemia Working Party of the EBMTJonathan Canaani, Bipin N Savani, Myriam Labopin, et al.
BMC Gastroenterology|November 27, 2014
Randomised, double-blind, placebo-controlled trial of oral budesonide for prophylaxis of acute intestinal graft-versus-host disease after allogeneic stem cell transplantation (PROGAST)Renate Schmelz, Martin Bornhäuser, Johannes Schetelig, et al.
Blood Advances|March 23, 2022
Deep sequencing in CD34+ cells from peripheral blood enables sensitive detection of measurable residual disease in AMLSebastian Stasik, Clara Burkhard-Meier, Michael Kramer, et al.
Blood|July 16, 2005
Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemiaMatthias Stelljes, Martin Bornhauser, Matthias Kroger, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 5, 2019
Comparable Long-Term Outcome after Allogeneic Stem Cell Transplantation from Sibling and Matched Unrelated Donors in Patients with Acute Myeloid Leukemia Older Than 50 Years: A Report on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationAvichai Shimoni, Myriam Labopin, Bipin Savani, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 15, 2012
Allogeneic hematopoietic cell transplantation in patients age 60-70 years with de novo high-risk myelodysplastic syndrome or secondary acute myelogenous leukemia: comparison with patients lacking donors who received azacitidineUwe Platzbecker, Johannes Schetelig, Jürgen Finke, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 25, 2018
Validation of the Revised Pretransplant Assessment of Mortality Score in Patients with Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Stem Cell TransplantationJan M Middeke, Frederike Kollinger, Henning Baldauf, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 23, 2008
Red blood cell transfusion dependence and outcome after allogeneic peripheral blood stem cell transplantation in patients with de novo myelodysplastic syndrome (MDS)Uwe Platzbecker, Martin Bornhäuser, Ulrich Germing, et al.
Pageof 41

Showing results (241-250 of 403) with videos related to

Sort By:
Pageof 41
British Journal of Haematology|January 21, 2017
The TP53 Pro72Arg SNP in de novo acute myeloid leukaemia - results of two cohort studies involving 215 patients and 3759 controlsEduard Schulz, Karin Lind, Wilfried Renner, et al.
Blood|February 24, 2021
Proof of concept for a rapidly switchable universal CAR-T platform with UniCAR-T-CD123 in relapsed/refractory AMLMartin Wermke, Sabrina Kraus, Armin Ehninger, et al.
Haematologica|March 4, 2017
Impact of ABO incompatibility on patients' outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the Acute Leukemia Working Party of the EBMTJonathan Canaani, Bipin N Savani, Myriam Labopin, et al.
BMC Gastroenterology|November 27, 2014
Randomised, double-blind, placebo-controlled trial of oral budesonide for prophylaxis of acute intestinal graft-versus-host disease after allogeneic stem cell transplantation (PROGAST)Renate Schmelz, Martin Bornhäuser, Johannes Schetelig, et al.
Blood Advances|March 23, 2022
Deep sequencing in CD34+ cells from peripheral blood enables sensitive detection of measurable residual disease in AMLSebastian Stasik, Clara Burkhard-Meier, Michael Kramer, et al.
Blood|July 16, 2005
Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemiaMatthias Stelljes, Martin Bornhauser, Matthias Kroger, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 5, 2019
Comparable Long-Term Outcome after Allogeneic Stem Cell Transplantation from Sibling and Matched Unrelated Donors in Patients with Acute Myeloid Leukemia Older Than 50 Years: A Report on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationAvichai Shimoni, Myriam Labopin, Bipin Savani, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 15, 2012
Allogeneic hematopoietic cell transplantation in patients age 60-70 years with de novo high-risk myelodysplastic syndrome or secondary acute myelogenous leukemia: comparison with patients lacking donors who received azacitidineUwe Platzbecker, Johannes Schetelig, Jürgen Finke, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 25, 2018
Validation of the Revised Pretransplant Assessment of Mortality Score in Patients with Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Stem Cell TransplantationJan M Middeke, Frederike Kollinger, Henning Baldauf, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 23, 2008
Red blood cell transfusion dependence and outcome after allogeneic peripheral blood stem cell transplantation in patients with de novo myelodysplastic syndrome (MDS)Uwe Platzbecker, Martin Bornhäuser, Ulrich Germing, et al.
Pageof 41